SLI
1.986,02
PKT
+13,07
PKT
+0,66
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
24.01.05 | Novartis Neutral | Sarasin Research | |
21.01.05 | Logitech Accumulate | Helvea | |
21.01.05 | Zurich Insurance Accumulate | Helvea | |
24.01.05 | Straumann Outperform | Credit Suisse First Boston | |
21.01.05 | Novartis Kaufen | Helaba Trust | |
21.01.05 | Zurich Insurance Buy | Sarasin Research | |
24.01.05 | Lonza Reduce | Sarasin Research | |
21.01.05 | Holcim Accumulate | Helvea | |
21.01.05 | Richemont Accumulate | Helvea | |
24.01.05 | Novartis Kaufen | Hamburger Sparkasse | |
21.01.05 | Roche Buy | Sarasin Research | |
21.01.05 | Richemont Buy | Sarasin Research | |
24.01.05 | Novartis Neutral | HypoVereinsbank | |
21.01.05 | ABB (Asea Brown Boveri) Neutral | Sarasin Research | |
21.01.05 | Richemont Buy | Sarasin Research | |
24.01.05 | ABB (Asea Brown Boveri) Kaufen | NATIONAL-BANK | |
20.01.05 | Swiss Life Buy | M.M. Warburg | |
21.01.05 | Lindt Neutral | Sarasin Research | |
20.01.05 | Logitech Buy | Sarasin Research | |
20.01.05 | Richemont Outperform | Goldman Sachs | |
20.01.05 | Lindt Underperform | Goldman Sachs | |
20.01.05 | Logitech Buy | Sarasin Research | |
20.01.05 | Zurich Insurance Buy | Sarasin Research | |
20.01.05 | Holcim Halten | Helaba Trust | |
20.01.05 | Novartis Akkumulieren | Independent Research | |
20.01.05 | UBS Buy | Sarasin Research | |
21.01.05 | Logitech Accumulate | Helvea | |
20.01.05 | Holcim Neutral | Sarasin Research | |
20.01.05 | Novartis Hold | SEB | |
21.01.05 | Holcim Accumulate | Helvea | |
20.01.05 | Novartis Neutral | Sarasin Research | |
21.01.05 | Novartis Buy | Helvea | |
19.01.05 | Novartis Equal-weight | Morgan Stanley | |
19.01.05 | Holcim In-Line | Goldman Sachs | |
20.01.05 | Logitech In-Line | Goldman Sachs | |
19.01.05 | Zurich Insurance Overweight | Lehman Brothers | |
21.01.05 | Novartis Kaufen | Helaba Trust | |
19.01.05 | Straumann Accumulate | Helvea | |
19.01.05 | Nestlé In-Line | Goldman Sachs | |
19.01.05 | SGS SA Neutral | Sarasin Research |